Brazilian Thalassemia Association protocol for iron chelation therapy in patients under regular transfusion

In the absence of an iron chelating agent, patients with beta-thalassemia on regular transfusions present complications of transfusion-related iron overload. Without iron chelation therapy, heart disease is the major cause of death; however, hepatic and endocrine complications also occur. Currently...

Descripción completa

Detalles Bibliográficos
Autores principales: Veríssimo, Monica Pinheiro de Almeida, Loggetto, Sandra Regina, Fabron Junior, Antonio, Baldanzi, Giorgio Roberto, Hamerschlak, Nelson, Fernandes, Juliano Lara, Araujo, Aderson da Silva, Lobo, Clarisse Lopes de Castro, Fertrin, Kleber Yotsumoto, Berdoukas, Vasilios Antonios, Galanello, Renzo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Associação Brasileira de Hematologia e Hemoterapia 2013
Materias:
Special Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3905826/
https://www.ncbi.nlm.nih.gov/pubmed/24478610
http://dx.doi.org/10.5581/1516-8484.20130106

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3905826/
https://www.ncbi.nlm.nih.gov/pubmed/24478610
http://dx.doi.org/10.5581/1516-8484.20130106

Ejemplares similares